Abstract
Evidence-based medicine is the cornerstone of clinical practice, but it is dependent on the quality of evidence upon which it is based. Unfortunately, up to half of all randomized controlled trials (RCTs) have never been published, and trials with statistically significant findings are more likely to be published than those without (Dwan et al., 2013). Importantly, negative trials face additional hurdles beyond study publication bias that can result in the disappearance of non-significant results (Boutron et al., 2010; Dwan et al., 2013; Duyx et al., 2017). Here, we analyze the cumulative impact of biases on apparent efficacy, and discuss possible remedies, using the evidence base for two effective treatments for depression: Antidepressants and psychotherapy.
| Original language | English |
|---|---|
| Pages (from-to) | 2453-2455 |
| Number of pages | 3 |
| Journal | Psychological Medicine |
| Volume | 48 |
| Issue number | 15 |
| DOIs | |
| Publication status | Published - 1 Nov 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Antidepressants
- bias
- citation bias
- depression
- psychotherapy
- reporting bias
ASJC Scopus subject areas
- Applied Psychology
- Psychiatry and Mental health
Fingerprint
Dive into the research topics of 'The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: The case of depression'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS